Eli Lilly slips in pre-market! New pill still under FDA scrutiny 💊

Open account Download free app

Eli Lilly shares are falling in pre-market trading following news of a delay by the U.S. FDA in approving a new oral weight-loss pill, which could become a significant product in the company’s portfolio. Markets typically react negatively to any postponement of key regulatory decisions, as it delays the product’s market launch, extends uncertainty over its potential sales, and temporarily limits possible revenue growth momentum. Such a reaction is typical and can create short-term pressure on the stock price.

In the longer term, however, the delay is not expected to significantly impact the company’s fundamentals, and the product itself has strong revenue potential. Clinical trials have shown promising results, and the market for weight-loss therapies continues to grow. Analysts remain moderately optimistic and still see Eli Lilly as having a meaningful opportunity to capture market share once the drug is approved. The company has extensive experience in the GLP‑1 segment and a strong portfolio, which further mitigates long-term risk.

Markets will be closely watching further FDA updates, clinical and sales reports, and regulatory developments in the pharmaceutical sector, all of which could affect the speed of the drug’s commercialization and its margins.

Source: xStation5

15 January 2026, 12:41 PM

MIDDAY WRAP: TSMC drives tech stocks; bank results in the background💡

15 January 2026, 11:13 AM

The parent company of Cartier and IWC reports earnings 💡What will investors be looking at in 2026❓

15 January 2026, 10:38 AM

TSMC Breaks Records! Explosive Results Confirm the Enduring AI Rally🚀

15 January 2026, 7:36 AM

⏬Oil and Silver Retreat on Trump

Stocks

Cookie name	Description
SERVERID
userBranchSymbol	Expiration date 1 day
test_cookie	Expiration date 1 hour
adobe_unique_id	Expiration date 364 days
__hssc	Expiration date 1 hour
SESSID	Expiration date 1 day
__cf_bm	Expiration date 1 hour
intercom-id-iojaybix	Expiration date 270 days
intercom-session-iojaybix	Expiration date 6 days
xtbCookiesSettings	Expiration date 364 days
TS5b68a4e1027
countryIsoCode
xtbLanguageSettings	Expiration date 364 days
userPreviousBranchSymbol	Expiration date 364 days
intercom-device-id-iojaybix	Expiration date 270 days
__cfruid
_cfuvid

Cookie name	Description
_gid	Expiration date 1 day
_gat_UA-98728395-1	Expiration date 1 hour
_gat_UA-121192761-1	Expiration date 1 hour
_gcl_au	Expiration date 89 days
_ga_CBPL72L2EC	Expiration date 729 days
_ga	Expiration date 729 days
__hstc	Expiration date 179 days
__hssrc
_vwo_uuid_v2	Expiration date 365 days
_ga_TC79BEJ20L	Expiration date 729 days
_vwo_uuid	Expiration date 365 days
_vwo_ds	Expiration date 29 days
_vwo_sn	Expiration date 1 hour
_vis_opt_s	Expiration date 99 days
_vis_opt_test_cookie
af_id	Expiration date 394 days
afUserId	Expiration date 730 days
AF_SYNC	Expiration date 6 days
AnalyticsSyncHistory	Expiration date 29 days

Cookie name	Description
MUID	Expiration date 389 days
_omappvp	Expiration date 3998 days
_omappvs	Expiration date 1 hour
_uetsid	Expiration date 1 day
_uetvid	Expiration date 389 days
_fbp	Expiration date 89 days
fr	Expiration date 89 days
_ttp	Expiration date 89 days
_tt_enable_cookie	Expiration date 89 days
hubspotutk	Expiration date 179 days
IDE	Expiration date 389 days
YSC
VISITOR_INFO1_LIVE	Expiration date 179 days
li_sugr	Expiration date 89 days
guest_id_marketing	Expiration date 729 days
guest_id_ads	Expiration date 729 days
guest_id	Expiration date 729 days
muc_ads	Expiration date 729 days
VISITOR_PRIVACY_METADATA	Expiration date 179 days
MSPTC	Expiration date 389 days

Cookie name	Description
bcookie	Expiration date 364 days
lidc	Expiration date 1 day
UserMatchHistory	Expiration date 29 days
bscookie	Expiration date 364 days
li_gc	Expiration date 179 days
personalization_id	Expiration date 729 days

Eli Lilly slips in pre-market! New pill still under FDA scrutiny 💊

Join over 2 000 000 XTB Group Clients from around the world